Crohn's disease activity: Quantitative contrast-enhanced ultrasound assessment

Abdominal Imaging

Volumn 37, Issue 3, 2012, Pages 369-376

  Wong, Daniel D ^a   Forbes, Geoff M ^a,b   Zelesco, Marilyn ^a   Mason, Rose ^a   Pawlik, Janina ^a   Mendelson, Richard M ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Contrast media; Crohn's disease; Inflammation; Microbubbles; Ultrasound

Indexed keywords

C REACTIVE PROTEIN; PERFLUTREN;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; COLONOSCOPY; CONTRAST ENHANCEMENT; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ECHOGRAPHY; ENDOSCOPE; FEMALE; HUMAN; INFLAMMATION; INTESTINE WALL; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGMOIDOSCOPY; TIME TO MAXIMUM PLASMA CONCENTRATION; ULTRASOUND SCANNER;

ADOLESCENT; ADULT; AGED; AREA UNDER CURVE; BIOPSY; C-REACTIVE PROTEIN; COLONOSCOPY; CONTRAST MEDIA; CROHN DISEASE; FEMALE; FLUOROCARBONS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SIGMOIDOSCOPY; STATISTICS, NONPARAMETRIC;

EID: 84863716535     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-011-9792-z     Document Type: Article

References (23)

1. Maconi G, Radice E, Greco S, Bianchi Porro G (2006) Bowel ultrasound in Crohn's disease. Best Pract Res Clin Gastroenterol 20(1):93-112
2. Migaleddu V, Quaia E, Scano D, Virgilio G (2008) Inflammatory activity in Crohn disease: ultrasound findings. Abdom Imaging 33(5):589-597
3. Horsthuis K, Bipat S, Bennink RJ, Stoker J (2008) Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: metaanalysis of prospective studies. Radiology 247(1):64-79
4. Braden B, Ignee A, Hocke M, Palmer RM, Dietrich C (2010) Diagnostic value and clinical utility of contrast enhanced ultrasound in intestinal diseases. Dig Liver Dis 42(10):667-674
5. Hatoum OA, Miura H, Binion DG (2003) The vascular contribution in the pathogenesis of inflammatory bowel disease. Am J Physiol Heart Circ Physiol 285(5):H1791-H1796
6. Ripolles T, Martinez MJ, Paredes JM, et al. (2009) Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy. Radiology 253(1):241-248
7. Girlich C, Jung EM, Iesalnieks I, et al. (2009) Quantitative assessment of bowel wall vascularisation in Crohn's disease with contrast-enhanced ultrasound and perfusion analysis. Clin Hemorheol Microcirc 43(1):141-148
8. Kratzer W, Schmidt SA, Mittrach C, et al. (2005) Contrast-enhanced wideband harmonic imaging ultrasound (SonoVue): a new technique for quantifying bowel wall vascularity in Crohn's disease. Scand J Gastroenterol 40(8):985-991
9. Quaia E, Migaleddu V, Baratella E, et al. (2009) The diagnostic value of small bowel wall vascularity after sulfur hexafluoride-filled microbubble injection in patients with Crohn's disease. Correlation with the therapeutic effectiveness of specific anti-inflammatory treatment. Eur J Radiol 69(3):438-444
10. Best WR, Becktel JM, Singleton JW, Kern FJr (1976) Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70(3):439-444
11. Mary JY, Modigliani R (1989) Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 30(7): 983-989
12. Lutgens MW, Vleggaar FP, Schipper ME, et al. (2008) High frequency of early colorectal cancer in inflammatory bowel disease. Gut 57(9):1246-1251
13. Rutgeerts P, Vermeire S, Van Assche G (2007) Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target? Gut 56(4):453-455
14. Lichtenstein GR, Abreu MT, Cohen R, Tremaine W (2006) American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology 130(3):940-987
15. Yoshida EM (1999) The Crohn's disease activity index, its derivatives and the inflammatory bowel disease questionnaire: a review of instruments to assess Crohn's disease. Can J Gastroenterol 13(1):65-73
16. Migaleddu V, Scanu AM, Quaia E, et al. (2009) Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn's disease. Gastroenterology 137(1):43-52
17. Angerson WJ, Allison MC, Baxter JN, Russell RI (1993) Neoterminal ileal blood flow after ileocolonic resection for Crohn's disease. Gut 34(11):1531-1534
18. Borley NR, Mortensen NJ, Jewell DP, Warren BF (2000) The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link. J Pathol 190(2):196-202
19. Taylor SA, Punwani S, Rodriguez-Justo M, et al. (2009) Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination - pilot study. Radiology 251(2):369-379
20. Girlich C, Jung EM, Huber E, et al. (2011) Comparison between preoperative quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound and operative macroscopic findings and results of histopathological scoring in Crohn's disease. Ultraschall Med 32(2):154-159
21. Serra C, Menozzi G, Labate AM, et al. (2007) Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn's disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent. Eur J Radiol 62(1):114-121
22. Carr ND, Pullan BR, Schofield PF (1986) Microvascular studies in non-specific inflammatory bowel disease. Gut 27(5):542-549
23. Bristol-Myers Squibb Medical Imaging Inc. (2002) Definity (perflutren lipid microsphere) product monograph.